These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2414116)

  • 21. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.
    Lundberg JM; Al-Saffar A; Saria A; Theodorsson-Norheim E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):163-8. PubMed ID: 3010140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
    Buckingham RE
    Br J Pharmacol; 1988 Mar; 93(3):541-52. PubMed ID: 3370388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
    Small DL; Bolzon BJ; Cheung DW
    Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pressor effect of centrally administered neuropeptide Y in rats: role of sympathetic nervous system and vasopressin.
    Vallejo M; Lightman SL
    Life Sci; 1986 May; 38(20):1859-66. PubMed ID: 3084899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
    Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenergic and neuropeptide Y mechanisms in guanethidine-sympathectomized rats.
    Benarroch EE; Schmelzer JD; Ward KK; Nelson DK; Low PA
    Am J Physiol; 1990 Aug; 259(2 Pt 2):R371-5. PubMed ID: 2386246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J; Kahan T; Lundberg JM
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of reserpine on the pressor responses to angiotensin in the conscious cat.
    Day MD; Owen DA
    Br J Pharmacol; 1970 Jun; 39(2):414-27. PubMed ID: 4393216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of neuropeptide Y in the nucleus tractus solitarius of rats: relationship with noradrenaline and vasopressin.
    Carter DA; Vallejo M; Lightman SL
    Peptides; 1985; 6(3):421-5. PubMed ID: 3840887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral administration of nifedipine on neuropeptide Y- and noradrenaline-induced vasoconstriction in the human forearm.
    Pernow J; Lundberg JM; Kaijser L
    Clin Physiol; 1989 Feb; 9(1):67-75. PubMed ID: 2706916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of tachyphylaxis due to angiotensin on the isolated aorta in rats. Effect of norepinephrine, tyramine, reserpine and phenoxybenzamine].
    Bloch R; Meyer J; Ehrhardt JD
    Therapie; 1973; 28(1):55-65. PubMed ID: 4354412
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of neuropeptide Y on the pressor responses to phenylephrine and to activation of the sympathetic nervous system in anaesthetized rats.
    Revington ML; McCloskey DI; Potter EK
    Clin Exp Pharmacol Physiol; 1987 Sep; 14(9):703-10. PubMed ID: 3442953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of alpha-1 adrenoceptor-mediated pressor responses to inhibition by Ca++ entry blockers in the pithed rat: arguments against the role of receptor reserve.
    Timmermans PB; Beckeringh JJ; Van Zwieten PA; Thoolen MJ
    J Pharmacol Exp Ther; 1987 Mar; 240(3):864-70. PubMed ID: 3031277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of the pressor response to angiotensin by amphetamine and ephedrine.
    Commarato MA; Lum BK
    Eur J Pharmacol; 1970 Apr; 10(1):25-33. PubMed ID: 4314997
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
    Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
    Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison of systemic vs. local effects.
    Pedrinelli R; Tarazi RC
    J Pharmacol Exp Ther; 1985 Jun; 233(3):643-9. PubMed ID: 2861275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
    Pedrinelli R; Tarazi RC
    J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.